Provider review
yourEra review: the headline is a six-month plan with a discount already taken off it
yourEra's banner says compounded GLP-1 from $79.20 a month. Two things are folded into that number and the site tells you one of them: it "reflects the 6-month plan". The other is the 20% discount auto-applied at checkout, which is where $79.20 comes from in the first place. What no page anywhere gives you is the price of a single month. On the evidence side it is more careful than most — no percentages, no timelines, no trials misquoted, just member stories labeled as atypical.
Publishes no aggregate outcome claim at all and labels every testimonial atypical — then folds a six-month term and a discount into one headline price.
Worth trusting if
- You want a seller that labels its success stories as atypical rather than presenting them as expectations
- You want the warning that compounded medicines are not FDA-approved printed beside the price
- You want a named company with a corporate form and an arbitration address you can write to
Be skeptical if
- You want to pay month to month, because no one-month price is published anywhere
- You are buying the microdosing product and want to know which drug is in it
- You want to know which pharmacy fills the prescription, or which clinician writes it
Compounded only
Phase 3 trials
Not named
None found
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Opens www.yourera.com. A link is not a recommendation to take anything.
Provenance
What yourEra actually dispenses
Regulatory category is the axis consumers are most reliably misled about, so it comes first. Every product below is sorted by what it legally is, not by what it costs.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide injection — Advertised at $79.20 a month, which is the six-month plan with 20% already deducted.
- Compounded tirzepatide injection — Advertised at $159.20 a month on the same six-month, already-discounted basis.
- Microdosing Protocols — Listed from $179 a month — the dearest of yourEra's four products.
Evidence
Has the molecule been tested for what it is sold for?
One row per product, graded on how far the published human evidence goes for the MOLECULE inside it, for the use it is sold for — not for the molecule in general, and never a claim about this seller. Nobody trials a compounded preparation; what a trial can tell you is whether the molecule has been tested for the thing it is being advertised to do. A molecule with phase 3 evidence for one outcome has none for another, and that distinction is where peptide marketing lives.
2
Molecules with human evidence
For the use they are sold for, out of 3 products reviewed here. The evidence belongs to the molecule, not to yourEra.
2
Registry records cited
Each read live from ClinicalTrials.gov, never from memory. None of them tested this company's product.
The comparison
What they claim, against what the trials show
Each claim below is quoted verbatim from yourEra’s own page, with the page it came from. Grading a paraphrase would prove nothing. Every row is the verdict at a glance — tap it to open the quote, the trial registry entries, and the full note behind that verdict.
Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim matches the trials
“Doctor-guided GLP-1 weight loss care, delivered to you. Finally lose weight without fighting hunger. Down 42 lbs in 4 months. Down 28 lbs in 5 months. 94 LBS LOST. Individual results vary and are not typical.”
Read on the yourEra site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, titrated to semaglutide 2.4 mg, mean weight reduction of about 15%. A 42-pound loss in four months sits far above that mean for that period, which is why the atypical label on the testimonial matters.
yourEra makes no aggregate claim at all — no percentage, no timeline, no trial cited anywhere — and the numbers it does publish are attached to named members and labeled as atypical. That distinction is the whole of this verdict. A figure like 42 pounds in four months is well beyond the STEP 1 mean for that stretch, and presented as an average it would be a clear overstatement; presented as one person's experience with the label individual results vary and are not typical, it is a testimonial, which is a different kind of statement and an honest one. The site does the same on every story it runs. What it does not do is give a reader anything to calibrate against, because it never says what a typical result looks like.1
Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim matches the trials
“Tirzepatide GLP-1/GIP. As low as $159.20 / mo, 6 month plan. In stock. Reviewed by a provider. Licensed US clinician. Compounded medications are not FDA-approved. Individual results vary.”
Read on the yourEra site, September 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly, mean reduction of roughly 21% at the top dose.
Nothing on this product reaches past SURMOUNT-1 because nothing quantifies an outcome. What yourEra publishes here is accurate and useful in a different way: it names the mechanism correctly as a dual GLP-1 and GIP agent, says a licensed clinician reviews the request, and states plainly beside the price that compounded medications are not FDA-approved. That sentence belongs exactly where they put it.2
Microdosing ProtocolsGLP-1 microdose (molecule not named) · Compounded (503A)No trial supports this claim
“Microdosing Protocols from $179 /mo.”
Read on the yourEra site, September 2026
No trial for this use
No trial can be matched to this product because yourEra never says what is in it. Checked on September 13, 2026 across every page of its own site that mentions it — the homepage product list, the individual products, the catalog page and a product address: the microdosing product carries a price and a name and nothing else. No molecule, no dose, no description. A trial record cannot be attached to an unnamed drug, and guessing which one it is would be inventing the evidence base.
This is the least described product on the site and the most expensive of the four, which is an unusual combination. Microdosing is not what either major trial studied in any case — STEP 1 and SURMOUNT-1 both titrated participants up to a maintenance dose and measured them there — so even a named molecule at a deliberately reduced dose would sit outside the published evidence rather than inherit it. With no molecule named at all there is nothing to weigh. Worth knowing that the site links a named physician's own article on microdosing GLP-1s, hosted off-site, which is more than most sellers offer and still not a description of what is being sold.
Dispensing chain
Who actually fills your prescription
Read the full account
No pharmacy is named. The terms refer to Pharmacies and Medical Groups as categories, note that prescriptions may be transferred among them without notice, and name none of them — nor is a compounding tier stated anywhere, so nothing says whether your medication is made to order under your prescription or dispensed ready-made. No prescribing clinician is named either; the cards say only that a licensed US clinician reviews the request. What yourEra does publish is a named physician's own writing, linked off-site — four pieces by Dr. Tom Lavin including one on microdosing GLP-1s. That is better than an anonymous blog, and it is not the same as telling you who would treat you.
Read on the yourEra site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Nothing published on the pages searched
Certificate of analysis readable
No lot report a buyer can open
Read the full testing account
No certificate of analysis, potency, purity or sterility result is published. The trust signals are testimonial — member stories with named first names and specific losses, a star rating, and before-and-after photographs — and every one carries a label saying results vary and are not typical. There is no aggregate outcome figure anywhere, which means nothing here overstates the trials and nothing here helps a reader work out what to expect. The one genuinely useful thing beside the price is the sentence that compounded medications are not FDA-approved, printed beside the price rather than in a footer.
Read on the yourEra site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
yourEra publishes no list of states. Its terms require that you be physically located in the same state as the shipping address on your account at the time of a consultation, which describes how telehealth law works rather than where this company operates. Checked September 13, 2026.
Read the full licensing claim
The company is named and the corporate form given — YourEra, Inc., governed by Delaware law, with a published postal address for opting out of arbitration. Its terms also state plainly that yourEra and the Medical Groups are not enrolled with Medicare or Medicaid, which is a disclosure most sellers omit. No individual clinician is named.
Read on the yourEra site, September 2026.
Regulatory
The FDA warning letter
Checked, and none found
Assessment
What holds up, and what does not
- It publishes no aggregate weight-loss figure, so nothing here overstates what the trials found.
- Every testimonial carries a label saying results vary and are not typical.
- It says compounded medications are not FDA-approved right beside the price, not in a footer.
Show 5 more
- It names its company, its corporate form and its governing law, with an arbitration opt-out address.
- It discloses that neither it nor its medical groups are enrolled with Medicare or Medicaid.
- It tells you the headline price reflects the six-month plan, in its own words.
- It links a named physician's own writing rather than anonymous blog posts.
- No FDA warning letter.
- The advertised price is a six-month plan with a 20% discount already taken off it.
- No one-month price appears anywhere — not on the homepage, the cards, or the product pages we tried.
- Its catalog pages showed no price at all when we checked them.
Show 4 more
- The microdosing product names no molecule and no dose, and is the dearest of its four products.
- No pharmacy is named, and its terms say prescriptions may move between pharmacies without notice.
- No prescribing clinician is named as part of the service.
- No trial is cited anywhere, so nothing connects its products to published evidence.
Verdict
The bottom line
On evidence this is one of the more careful sellers in the batch — it makes no aggregate claim and marks every success story atypical, which is the right way to use a testimonial. On price it is one of the least clear: the number in the banner is a six-month commitment with a discount already applied, and the cost of a single month is published nowhere. Ask for that figure before you start.
Opens www.yourera.com. A link is not a recommendation to take anything.
Two things folded into one number
yourEra's banner:
"Compounded GLP-1 from $79.20/month · 20% discount auto-applied at checkout"
The site tells you one of the two things inside that figure, and to its credit it tells you plainly:
"$79.20/month reflects the 6-month plan."
The other is in the banner itself. $79.20 is 20% off $99, a figure that appears in the page's own data. The tirzepatide price works the same way: $159.20 is 20% off $199.
So the advertised price is a six-month commitment with a discount already deducted. What no page gives you is the cost of a single month. We checked the homepage, the products, the catalog page and a product address on 13 September 2026; the last two showed no price at all.
Full analysis — 2 more sectionsWhere it is better than most · The product it will not describe
Where it is better than most
On the evidence side, yourEra is careful in a way this batch mostly was not.
There is no aggregate claim anywhere — no "average 18%", no "full results in 2–3 months", no trial named and then misplaced. What it publishes instead is member stories:
"94 LBS LOST" · "Down 42 lbs in 4 months" · "Down 28 lbs in 5 months"
Each one labeled "Individual results vary and are not typical."
That label is doing real work. Forty-two pounds in four months is well beyond the STEP 1 mean for that stretch 1. Presented as an average it would be a plain overstatement. Presented as one member's experience and marked atypical, it is a testimonial — a different kind of statement, and an honest one.
The cost is that a reader gets no calibration at all. yourEra never says what a typical result looks like.
The product it will not describe
Four products in its catalog:
Semaglutide from $79/mo · Tirzepatide from $159/mo · NAD+ from $170/mo · Microdosing Protocols from $179/mo
The microdosing product is the most expensive of the four and the only one with no description at all — no molecule, no dose, nothing.
Microdosing also sits outside the published evidence regardless. Both major trials titrated participants up to a maintenance dose and measured them there 1 2, so a deliberately reduced dose is a different treatment rather than a cheaper share of the same one.
yourEra does link a named physician's own article on microdosing GLP-1s, hosted off-site. That is more than most sellers offer, and it is still not a description of what is in the bottle.
Questions
Frequently asked questions
Is compounded GLP-1 really $79.20 a month?
On a six-month plan, with a 20% discount already applied. yourEra says the first part itself — the figure reflects the 6-month plan — and the discount is in the banner beside it. No one-month price is published anywhere on the site.
What would one month cost?
The site doesn't say. We checked the homepage, the products, the catalog page and a product address on September 13, 2026 and found no monthly figure at all; the last two showed no price. Ask before you start, because the advertised number assumes you are committing to half a year.
Should I believe the member stories?
Treat them as what they are labeled as. Every one carries the note that results vary and are not typical, and a figure like 42 pounds in four months is well beyond the average the trials reported for that stretch. A labeled testimonial is an honest thing to publish; it just isn't a guide to what you should expect.
What is the microdosing protocol?
yourEra doesn't say. It carries a price and a name and no molecule, no dose and no description — and it is the dearest of the four products. Microdosing also sits outside what either major trial studied, since both titrated participants up to a full maintenance dose before measuring.
Who makes the medication?
yourEra doesn't name a pharmacy. Its terms refer to pharmacies and medical groups as categories and add that prescriptions may be transferred among them without notice, so you would not necessarily know which one filled a given order.
Glossary
Key terms
Show definitions
- Titration
- Starting at a low dose and stepping up over weeks to a target. Both major weight-loss trials titrated participants up and measured results at the maintenance dose, which is why results from a deliberately lower dose are not covered by them.
- Compounded
- Made to order by a pharmacy for an individual patient rather than manufactured and approved as a finished product. Compounded drugs are not FDA-approved and the FDA has not evaluated their safety, effectiveness or quality.
- STEP 1
- The phase 3 trial of once-weekly semaglutide 2.4 mg for weight loss — 1,961 adults over 68 weeks, published in the New England Journal of Medicine in 2021.
Compare
Others selling what yourEra sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off yourEra's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 2 sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, titrated to a 2.4 mg maintenance dose. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks at 5, 10 and 15 mg once weekly. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.